Literature DB >> 15205226

Clinical and ultrastructural findings in mare's tail lines of the corneal epithelium.

S Akhtar1, A J Bron, K M Meek, L W Voon.   

Abstract

AIMS: Mare's tail lines are uncommon, grey, parallel, tapering epithelial lines, which may give rise to discomfort or to visual symptoms. The authors report the clinical and ultrastructural findings in two patients
METHODS: Therapeutic debridement was performed in two patients suffering from mare's tail disorder. The loosely attached epithelium was removed and fixed in glutaraldehyde containing cuprolinic blue and processed in a standard fashion for electron microscopy.
RESULTS: Ultrastructural studies showed an avascular, collagenous pannus extending under the whole of the excised epithelium in each case and separated from it by a thickened basal lamina like zone. The basal laminar material extended into the epithelium in folds, in keeping with the clinical features. Interesting ultrastructural features included: (1) a lack of hemidesmosomes in relation to the basal laminar material; (2) trapping of degenerate keratocytes within the invaginating basal laminar folds; (3) an unusual regularity and fine dimensions of the collagen fibrils and proteoglycans making up the subepithelial pannus. The basal laminar material contained proteoglycans and small fibres similar in appearance to long spacing collagen.
CONCLUSIONS: Mare's tail lines are caused by basal laminar material, assumed to be chiefly of epithelial origin, which invaginates the corneal epithelium. The presence of occasional keratocytes within the invaginating folds suggests that there may be a stromal contribution to the disorder. The visibility of mare's tail lines in the focal beam of the slit lamp is likely to be related to the thickness and light scattering properties of the invaginations and of the subepithelial deposits. Tractional forces, imposed by lid action, could explain their horizontal disposition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15205226      PMCID: PMC1772224          DOI: 10.1136/bjo.2003.033456

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  MICROCYSTIC DYSTROPHY OF THE CORNEAL EPITHELIUM.

Authors:  D G COGAN; D D DONALDSON; T KUWABARA; D MARSHALL
Journal:  Trans Am Ophthalmol Soc       Date:  1964

2.  Fingerprint-like lines in the cornea.

Authors: 
Journal:  Am J Ophthalmol       Date:  1950-05       Impact factor: 5.258

3.  Microcystic corneal dystrophy.

Authors:  P R Laibson
Journal:  Trans Am Ophthalmol Soc       Date:  1976

4.  Unusual epithelial changes in a case of combined corneal dystrophy of Fuchs.

Authors:  G T Schroeder; C Hanna
Journal:  Am J Ophthalmol       Date:  1971-09       Impact factor: 5.258

5.  Electron microscopic studies on Fuchs' combined dystrophy. II. Anterior portion of the cornea.

Authors:  T Iwamoto; A G DeVoe
Journal:  Invest Ophthalmol       Date:  1971-01

6.  Observations on Cogan's microcystic dystrophy of the corneal epithelium.

Authors:  D Guerry
Journal:  Trans Am Ophthalmol Soc       Date:  1965

7.  Fabry's disease: ocular findings in a female carrier. A light and electron microscopy study.

Authors:  T A Weingeist; F C Blodi
Journal:  Arch Ophthalmol       Date:  1971-02

Review 8.  Superficial lines and associated disorders of the cornea.

Authors:  N A Brown; A J Bron
Journal:  Am J Ophthalmol       Date:  1976-01       Impact factor: 5.258

9.  Irregularities of Bowman's membrane.

Authors:  H E Kaufman; J W Clower
Journal:  Am J Ophthalmol       Date:  1966-02       Impact factor: 5.258

10.  [Maplike dystrophy of the cornea (author's transl)].

Authors:  I Egerer
Journal:  Klin Monbl Augenheilkd       Date:  1980-12       Impact factor: 0.700

View more
  1 in total

1.  Corneal nerve architecture in a donor with unilateral epithelial basement membrane dystrophy.

Authors:  Jiucheng He; Haydee E P Bazan
Journal:  Ophthalmic Res       Date:  2013-01-10       Impact factor: 2.892

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.